Point72 Asset Management’s Pulse Biosciences PLSE Stock Holding History

Point72 Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Buy	+106,457	New	+$2.51M	﹤0.01%	2142

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Point72 Asset Management's PLSE Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 106,457 shares worth $2.95M. The stake represents ﹤0.01% of the portfolio and ranks #2142 among its holdings.

106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Point72 Asset Management held 106,457 shares of Pulse Biosciences worth $2.95M as of Q2 2026.
Pulse Biosciences was a new Point72 Asset Management position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2142 holding.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.